Access hsTnI (High Sensitivity Troponin I) Assay

Confidently report accurate results with the first true high-sensitivity troponin I assay cleared by the FDA

Access hsTnI is a true high-sensitivity troponin assay that demonstrates <10% CV at the upper reference limits (URL) for men and women and detects troponin in >50% of the healthy population. In an independent study, the assay detected troponin in >99% of healthy men and women.¹ Access hsTnI provides reliable test results that your physicians can count on to make faster and more confident decisions about patient management.

Product Variants

This product may not be available in your country or region at this time. Please contact your Beckman Coulter sales representative or distributor for more information.

Request more info

Benefits of the Access hsTnI High-sensitivity Troponin I Assay

Delivers quality results with a new robust design to minimize the effects of pre-analytical variability and known interferences
Demonstrates optimal precision at concentrations ~10x lower than previous generations of assays
Enables easier interpretation of test results by using whole-number reporting
Increases testing flexibility as the only high-sensitivity assay to use either plasma or serum samples
Accurately identifies ≥94% of true acute myocardial infarction (AMI) patients in as little as one hour after presentation
Enables more accurate identification of women with AMI by providing separate sex-specific upper reference limits
Provides >99% confidence in ruling out AMI when a patient’s troponin result is below the URL

Access hsTnI delivers tangible advances in patient care

A multicenter prospective study to establish the 99th percentile URL in a population of healthy adults was conducted. Study participants had no known cardiovascular diseases, other acute or chronic diseases, or infections. (See Tables 1 and 2.)

Table 1. 99th Percentile URL of a Healthy Population: UniCel DxI

Sample Type	Population	N	99th percentile pg/mL (ng/L)	95% CI pg/mL (ng/L)
Lithium heparin plasma	Females	593	14.9	10.1–27.1
	Males	495	19.8	15.9–38.4
	Overall	1,088	17.9	14.7–27.1
Serum	Females	592	13.6	10.0–25.6
	Males	493	19.8	15.4–44.8
	Overall	1,085	18.1	14.3–25.6

Table 2. 99th Percentile URL of a Healthy Population: Access 2

Sample Type	Population	N	99th percentile pg/mL (ng/L)	95% CI pg/mL (ng/L)
Lithium heparin plasma	Females	595	11.6	8.4–18.3
	Males	494	19.8	14.0–42.9
	Overall	1,089	17.5	12.6–20.7
Serum	Females	595	11.8	8.7–18.7
	Males	493	19.7	14.3–44.3
	Overall	1,088	18.2	13.1–23.1

Access hsTnI provides sex-specific cutoff values.

Assay details

DxI Sample Type/Size	Lithium heparin plasma, serum/55μL
10% CV LoQ	5.6 pg/mL (ng/L)
20% CV LoQ	2.3 pg/mL (ng/L)
LoD	2.3 pg/mL (ng/L)

Access 2 Sample Type/Size	Lithium heparin plasma, serum/55μL
10% CV LoQ	4.1 pg/mL (ng/L)
20% CV LoQ	2.0 pg/mL (ng/L)
LoD	2.0 pg/mL (ng/L)

View all documents

Brochure Access hsTnI Scientific Literature

Review the latest peer-reviewed analytical and clinical evaluations highlighting the value Access hsTnI can bring to your patients.

Download

Article The Advantages of High-sensitivity Troponin Tests

High-sensitivity troponin assays detect circulating troponin at lower levels and provide improved diagnostic clarity. Find out how these tests support accelerated decision making and improved care for patients with suspected acute coronary syndrome.

¹Pretorius, C.J., et. al. “A critical evaluation of the Beckman Coulter Access hsTnI: Analytical performance, reference interval and concordance.” Clinical Biochemistry, vol. 55, 2018 May, pp. 49–55. https://doi.org/10.1016/j.clinbiochem.2018.03.003. Accessed 22 June 2018.

Information addressed to health professionals. The products presented on this site are for professional use only, and, where applicable, comply with the requirements of the IVD Directive 98/79 / EC. Instructions for use must be consulted before using these products.

© 2020 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.

U.S. Government Users Restricted Rights - As per GSA ADP Schedule Contract with Beckman Coulter, Inc., the use, duplication or disclosure is restricted as follows: Beckman Coulter hereby authorizes user to copy those documents published on the World Wide Web by Beckman Coulter, for noncommercial use, and only within the user's organization. Except as expressly provided above, nothing contained herein shall be construed as granting any license or right under any Beckman Coulter copyright. Nothing contained herein shall be construed as granting by implication, estoppel or otherwise any license or right under any patent or trademark of Beckman Coulter or any third party.

Choose your country/region and language

Country or Region

Language

Access hsTnI (High Sensitivity Troponin I) Assay

Benefits of the Access hsTnI High-sensitivity Troponin I Assay

Assay details

DxI Sample Type/Size

10% CV LoQ

20% CV LoQ

LoD

Access 2 Sample Type/Size

10% CV LoQ

20% CV LoQ

LoD

Brochure Access hsTnI Scientific Literature

Article The Advantages of High-sensitivity Troponin Tests

Available on These Immunoassay Analyzers

Access 2

DxI 600

DxI 800

Power Link